New hope for bleeding disorder: experimental drug HMB-002 enters human testing
NCT ID NCT06754852
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 28 times
Summary
This study tests a new medicine, HMB-002, in 108 adults with von Willebrand disease (types 1 and 2). The goal is to check if the drug is safe, how the body processes it, and whether it helps control bleeding. Participants will receive either one or several doses of the drug, and researchers will monitor for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fiona Stanley Hospital
NOT_YET_RECRUITINGMurdoch, Perth, WA 6150, Australia
-
Richmond Pharmacology
RECRUITINGLondon, SE1 1YR, United Kingdom
-
Royal Prince Alfred Hospital
RECRUITINGCamperdown, Sydney, NSW 2050, Australia
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, VIC 3004, Australia
Conditions
Explore the condition pages connected to this study.